Study Summary:
We are currently conducting a Type 2 Diabetes study measuring the effectiveness of dapagliflozin in patients currently taking Actos (proglitazone) only.
Qualified Participants Must:
• Be 12-45 years of age
•
Have Type 2 Diabetes
•
Currently be on Actos only
•
Have no previous participation in a trial with dapagliflozin
Qualified Participants May Receive:
Medical care and supervision, labs, and study medication at no cost, and possible compensation of up to $700 for participating in the study.